Senior Director, Drug Substance Development and Manufacturing (Peptide) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kailera Therapeutics · 21 hours ago

Senior Director, Drug Substance Development and Manufacturing (Peptide)

Kailera is committed to developing therapies that empower individuals to transform their lives and enhance their health. They are seeking a Senior Director, Drug Substance Development and Manufacturing to lead outsourced manufacturing operations and drive technical excellence across the manufacturing lifecycle.

BiotechnologyPharmaceuticalTherapeutics

Responsibilities

In collaboration with senior leadership, direct and lead all process development, scale-up, technology transfer, and validation activities for peptide drug substance manufacturing across all Contract Development and Manufacturing Organizations (CDMOs), ensuring strategic alignment and operational excellence
Establish and drive continuous improvement initiatives focused on enhancing manufacturing efficiency, enabling cost reduction, and establishing strategic redundancies across the CDMO network
Define the long-term vision for manufacturing by maintaining a deep knowledge of industry trends, technological advancements, green manufacturing processes, and emerging regulatory changes to ensure a competitive and compliant strategy
Manage and enforce CDMO performance against key project timelines, deliverables, and costs, holding partners accountable to agreed-upon expectations
Lead the negotiation and execution of complex technical agreements and work orders with CDMO partners, ensuring clarity and successful delivery of manufacturing campaigns
Oversee budget planning and forecasting for all outsourced drug substance manufacturing activities
Serve as the strategic lead for drug substance activities, driving seamless collaboration across Analytical Development, Formulation, Quality Assurance, and Regulatory Affairs to ensure cohesive program execution
Oversee the preparation and completion of drug substance modules (e.g., Module 3) for all regulatory dossiers (e.g., IND, NDA), partnering closely with Regulatory Affairs to ensure timely and compliant global submissions
Direct the preparation and final authorship of high-quality technical reports, executive summaries, and presentations to effectively communicate results and progress to internal leadership and external stakeholders

Qualification

Peptide drug developmentSynthetic manufacturing techniquesRecombinant manufacturing techniquesRegulatory knowledgeProcess validationTechnical transfersProcess optimizationDetail orientationCross-functional collaborationCritical thinkingCommunication skills

Required

Minimum of 10+ years of progressive, relevant experience in drug substance development and manufacturing. This must include deep expertise in both synthetic and recombinant manufacturing approaches
Hands-on experience with the synthesis and manufacturing of peptides is mandatory
Demonstrated track record in managing clinical-scale supply, process characterization and optimization, technical transfers, and process validation activities
Sound technical skills in applying scientific principles to complex process design, implementation, and successful technology transfer
Regulatory Knowledge: Solid knowledge of current Good Manufacturing Practices (cGMPs), Quality systems, and global regulatory requirements (e.g., FDA, EMA)
Proven experience with the drafting, review, and authoring of CMC sections for major global regulatory submissions (e.g., IND, NDA, MAA)
Exceptional solution-based critical thinking skills and the ability to operate with a keen sense of urgency and an entrepreneurial spirit, focused on the successful execution of complex drug development plans
Demonstrated ability to ensure accountability of self and others, coupled with strong detail-orientation to proactively identify and mitigate risks and issues
Ability to strategically contribute to and manage multiple concurrent projects; assess complex inter-relationships across various product development disciplines; and identify critical gaps that may impact key milestones
Proven success in building and maintaining strong, effective relationships with Contract Development and Manufacturing Organizations (CDMOs) to drive performance and manage risk
Demonstrated ability to lead and contribute effectively to cross-functional teams to advance complex projects to completion
Excellent verbal and written communication skills with a proven ability to build internal and external relationships and influence senior stakeholders

Preferred

Experience in a small company or start-up environment is strongly preferred

Benefits

Comprehensive health coverage
Flexible time off
Paid holidays
Year-end shutdown
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants

Company

Kailera Therapeutics

twittertwittertwitter
company-logo
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Funding

Current Stage
Growth Stage
Total Funding
$1B
Key Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M

Leadership Team

leader-logo
Ronald Renaud
President & CEO
linkedin
leader-logo
Paul Burgess
Chief Operating Officer and Chief Business Officer
linkedin
Company data provided by crunchbase